Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 9Withdrawn 1Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 70Lymphoid 58Other hematologic neoplasm 27Gastrointestinal 8Thoracic 4Myeloid 3Genitourinary 3CNS 3Breast 3Other 2Tumor-Agnostic 1Sarcoma 1Other solid neoplasm 1Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Lymphoma 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Doxorubicin 25Radiotherapy 16apatinib 15Cyclophosphamide 15Ifosfamide 13anlotinib 12camrelizumab 10Temozolomide 9Imatinib Mesylate 9Vincristine 8Surgical Procedures, Operative 7Neoadjuvant Therapy 7Methotrexate 7Drug Therapy 7Dactinomycin 5Blood Specimen Collection 5fludarabine phosphate 4Paclitaxel 4Immune Checkpoint Inhibitors 4Etoposide 4Docetaxel 4Carboplatin 4toripalimab 3pembrolizumab 3Trabectedin 3Topotecan 3Surveys and Questionnaires 3Radiation Dose Hypofractionation 3Nivolumab 3Melphalan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Dexamethasone × Sarcoma × Clear all
NCT00003423 2013-12-19

Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
100 enrolled
LymphoidSarcoma

Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡